Atlas Trials

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Clinical trial NCT00381901 · COMPLETED

Trial details

NCT number
NCT00381901
Sponsor
National Cancer Institute, France
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2006-05-01
Primary completion
2011-05-01
Enrollment
3400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.